Porto, Portugal
+351 960 245 977
fbnsantos@fbnsantos.com

Category: cancer research

Robotics | IoT

Lung Cancer Patient First to Undergo CRISPR Gene Editing

The CRISPR-Cas9 “drag-and-drop” gene editing technique has been used in its first human trial, reports Nature. Scientists at Sichuan University in Chengdu, China began a trial last month to treat a lung cancer patient. “Earlier clinical trials using cells edited with a different technique have excited clinicians. The introduction of CRISPR, which is simpler and more efficient than other techniques, will probably accelerate the race to get gene-edited cells into the clinic across the world,… read more

Detecting Cancer Early With Nanosensors and a Urine Test

How might cancer detection, treatment, and prevention change if cancer could be diagnosed by peeing in a cup? According to Dr. Sangeeta Bhatia, about two-thirds of cancer deaths worldwide are probably preventable by techniques we already have in hand. Her laboratory is working to apply those techniques, and at Singularity University’s Her laboratory is working to apply those techniques, and at Singularity University’s Exponential Medicine conference, she shared details of an exciting project: using nanosensors… read more

CRISPR Targets Cancer in First Human Trial — What You Need to Know

It’s happening: as early as later this year, the gene-editing power tool CRISPR could be used in its first ever human trial. On Tuesday June 21, an advisory panel from the National Institute of Health (NIH) green lighted a proposal to use the game changing technique to tackle three different kinds of cancer. Scientists at the University of Pennsylvania (UPenn), who are spearheading the small trial, hope to use the technique to edit genes in… read more

Can DNA Nanobots Successfully Treat Cancer Patient? First Human Trial Soon

“No, no it’s not science fiction; it’s already happening,” said Ido Bachelet to a somewhat incredulous audience member at a London event late last year. Bachelet, previously of Harvard’s Wyss… read more